Developer docs
API playgroundTry for free, no card

Search company profiles

Bonraybio

Full company profile

uuid000epbj

Namestring
Bonraybio
Legal namestring
邦睿生技股份有限公司
Websiteurl
bonraybio.com
Company typeenum
Public
Founded yearint
2016
Descriptiontext

Bonraybio Co., Ltd. (邦睿生技股份有限公司) is a Taiwan-based medical device company specializing in male infertility diagnostic solutions under the LensHooke brand. Founded in 2016 by a team with more than 10 years of medical instrument development experience, the company is headquartered in Taichung City, Taiwan, with wholly-owned subsidiary offices in Ontario, California (USA) and Ziyang City, Sichuan (China), and completed its IPO on the Taiwan Stock Exchange (ticker 6955) in December 2024 following a 2023 Emerging Stock Board (興櫃) listing. The company targets IVF centers, fertility clinics, andrology laboratories, and urology practices across more than 18 countries, with a particular focus on the historically underserved male-factor infertility diagnostic workflow.

The company's product portfolio forms an integrated platform called MITS (Male Infertility Total Solution), combining three automated semen analyzers (X1 PRO, X3 PRO, X12 PRO), two sperm DNA fragmentation test kits (R10 Plus, R11 Plus), two sperm separation devices (CA0, CA1), and the C-KUP liquefaction test cup. Core technology is AI-powered computer vision applied to microscopic sperm image analysis, paired with novel sperm chromatin dispersion detection methods; the X12 PRO received FDA 510(k) clearance in June 2025 as the world's first FDA-approved sperm DNA fragmentation test, and CA0/CA1 received FDA approval in October 2022. The IP portfolio comprises 111 global patent applications (93 granted, 18 pending) and 70 registered trademarks across Taiwan, China, the USA, and Europe.

Bonraybio monetizes through a hybrid model combining capital equipment sales (instruments placed at IVF labs and clinics) with recurring consumable reagent sales (R10/R11 Plus test kits tied to installed analyzers), supplemented by aftermarket service. Pricing is quote-based and not publicly disclosed; all sales are executed via an extensive distributor network, with Hamilton Thorne (USA) and nal von minden GmbH (Germany) as core channel partners alongside regional distributors across Italy, South Korea, Thailand, Vietnam, Israel, the UAE, Turkey, and others. The company is heavily event-driven, participating in major reproductive medicine exhibitions (MEDICA, ASRM, ESHRE, CSRM) and conducting global MITS hands-on workshops to train distributors and engage embryologists and andrologists.

Short descriptiontext

Bonraybio Co., Ltd. (Taiwan) develops AI-powered male infertility diagnostic solutions under the LensHooke brand — automated semen analyzers, sperm DNA fragmentation test kits, and sperm separation devices — serving IVF clinics, fertility centers, and andrology laboratories across 18+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersTaichung, Taiwan
HQ citystring
Taichung
HQ countrystring
Taiwan
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
automated semen analysis, sperm DNA fragmentation testing, male infertility diagnostics, IVF laboratory equipment, andrology diagnostic devices
Industry1 code
PRIMARYHLAKAOAD
Male Reproductive & Sexual Medicine (Andrology)
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Diagnostic Devices — Andrology / Male Infertility
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Hardware Sales
TypeOne Time License
Description

Sale of automated semen analysis instruments (X1 PRO, X3 PRO, X12 PRO) and sperm separation devices (CA0, CA1). These are capital equipment purchases made by IVF laboratories, fertility clinics, and hospitals.

bonraybio.com
2Consumable Reagent Kits
TypeUsage Based
Description

Recurring sales of sperm DNA fragmentation test kits (R10 Plus, R11 Plus) and other reagents. These consumables are used with the company's instruments and represent a recurring revenue stream tied to testing volume.

bonraybio.com
3Aftermarket Services and Support
TypeSubscription Recurring
Description

Technical support, maintenance services, and potentially software updates for installed base of instruments in laboratories worldwide.

bonraybio.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels9 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure
Pricing details1 tier
1No public pricing tiers disclosed
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing through distributor network. No public pricing available on company website.

bonraybio.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1LensHooke
Description

Brand for male infertility total solutions including semen analysis systems, sperm DNA fragmentation tests, and sperm separation devices

bonraybio.com
+1 more record
Core offering1 text field

Bonraybio manufactures and sells AI-powered medical diagnostic devices and consumables under the LensHooke brand to provide a complete Male Infertility Total Solution. Its core offerings include automated semen quality analyzers (LensHooke X1 PRO, X3 PRO, X12 PRO), sperm DNA fragmentation test kits (R10 Plus, R11 Plus), sperm separation devices (CA0, CA1) used in IVF preparation, and the C-KUP liquefaction test cup. The portfolio is sold to IVF centers, fertility clinics, andrology laboratories, and urology practices globally through distributors and direct channels.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • DFI minimized in samples processed by CA0
+3 more records
Product overview1 text field

Bonraybio (邦睿生技) offers the LensHooke brand of male infertility diagnostic solutions, consisting of a platform-plus-modules architecture called MITS (Male Infertility Total Solution). The portfolio includes three automated semen analysis systems (X1 PRO, X3 PRO, X12 PRO), two sperm DNA fragmentation test kits (R10 Plus, R11 Plus), and two sperm separation devices (CA0, CA1), plus the C-KUP liquefaction test cup. These products work together to provide comprehensive male fertility testing from basic semen analysis to advanced DNA fragmentation assessment and sperm selection for assisted reproduction.

Product and service8 records
1LensHooke X1 PRO Semen Quality Analyzer
CategoryAutomated Semen Analyzer (Capital Equipment)
Description

Fully-automatic AI-assisted semen quality analyzer for IVF clinics and andrology labs; provides rapid, simple, and standardized examination of pH, sperm concentration, motility, and morphology. Installed in 100+ US labs and clinics since 2019 via Hamilton Thorne.

2LensHooke X3 PRO Semen Quality Analyzer
CategoryAutomated Semen Analyzer (Capital Equipment)
Description

Automated semen quality analyzer with an easy-to-use design and high-precision features for sperm analysis; targeted at clinical andrology labs and fertility clinics needing reliable routine semen inspection.

3LensHooke X12 PRO Fully-Automatic Sperm Analysis System
CategoryAutomated Semen Analyzer with DNA Fragmentation Testing (Capital Equipment)
Description

Fully-automatic sperm analysis system combining AI-powered semen quality analysis with sperm DNA fragmentation testing on a single platform; intended for IVF clinics, andrology labs, and research institutions performing advanced male fertility diagnostics.

4LensHooke R10 Plus Sperm DNA Fragmentation Rapid Test Kit
CategorySperm DNA Fragmentation Test Kit (Consumable)
Description

Consumable reagent kit using sperm chromatin dispersion technology for rapid, accurate assessment of sperm DNA fragmentation; used by fertility clinics and andrology labs that do not have access to flow cytometry.

5LensHooke R11 Plus Sperm DNA Fragmentation Test Kit
CategorySperm DNA Fragmentation Test Kit (Consumable)
Description

Reagent kit designed to detect sperm DNA double-strand breaks (DSB) — a marker scientifically correlated with miscarriage and embryo aneuploidy; positioned as the only commercially available reagent kit for DSB detection.

6LensHooke CA0 Sperm Separation Device
CategorySperm Separation Device (Capital Equipment / Procedure Tool)
Description

Sperm separation device using live motile sorting technology for IVF preparation; delivers consistent sperm selection efficiency for both normal and abnormal semen samples without centrifugation. Clinically adopted in leading hospitals including centers in Chengdu, China.

7LensHooke CA1 Sperm Separation Device
CategorySperm Separation Device (Capital Equipment / Procedure Tool)
Description

Variant of the CA0 sperm separation device providing centrifugation-free sperm selection for fertility treatments; part of the LensHooke live motile sorting product line.

8C-KUP Liquefaction Test Cup
CategorySemen Testing Consumable
Description

Single-use liquefaction test cup designed to avoid cross-infection risks during semen testing, including coronavirus-related contamination concerns in semen samples; used as a consumable with the LensHooke analyzer workflow.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership11 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ DistributorAnnounced on2019-01-01
Description

Exclusive US distributor for LensHooke products including X1 PRO semen analysis system, X12 PRO, and CA0 sperm separation device. Partnership established from 2019. Hamilton Thorne assists Bonraybio with US market exhibitions including ASRM annual meetings. Over 100 US labs and clinics have adopted LensHooke products through this channel.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Germany distributor for LensHooke Male Infertility Total Solution portfolio including X1 PRO, R10, X12 PRO, and CA0. Organized MITS workshop in Göttingen, Germany and AGRBM congress participation. Over 80 IVF centers and 300 embryologists engaged through German market activities.

3Al-RAD Ltd
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Israel distributor conducting LensHooke marketing events including visits to IVF centers and hospitals for product demonstrations. Received positive feedback on X1 PRO and CA0 products.

bonraybio.com
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

UAE distributor participating in Medlab Middle East exhibition with Bonraybio. Booth Z6.H20 showcasing LensHooke product line.

Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Italy distributor for LensHooke products. Organized successful MITS workshop in Milan with 12 reproductive doctors and embryologists. Supported ESHRE 2024 participation.

6CNC Biotech
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

South Korea distributor co-organizing Korean Society reproductive medicine conference and MITS workshops at CNC headquarters. Strong agreement on future trends including sperm DNA fragmentation testing and centrifugation-free sperm separation.

bonraybio.com
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Vietnam distributor, one of the leading IVF companies in Vietnam. Organized MITS seminar at Vinmec Hospital Hanoi with 30 doctors and embryologists. Showcased X1 PRO, R10/X12 PRO, and CA0 products.

8A.P.TEC (Thailand) Co., Ltd.
Strategic tierMajorTypeChannel Partner/ Reseller/ Distributor
Description

Thailand distributor co-organizing workshop with ThaiSRM (Thai Society for Reproductive Medicine) and Siam Fertility Clinic. Focused on IUI treatment applications.

bonraybio.com
9ARKİM MEDİKAL
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Turkey distributor participating in expoMED Eurasia exhibition. Over 100 doctors and visitors engaged at booth.

bonraybio.com
10First Capital Securities Corporation (第一金證券)
Strategic tierMinorTypeOthers
Description

Stock affairs agent for listed company shareholder services. Contact: 02-2563-5711

bonraybio.com
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Support partner for ESHRE 2024 exhibition in Amsterdam, Netherlands.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Direct competitor and simultaneously Bonraybio's exclusive US distributor for LensHooke products. Hamilton Thorne offers CASA (computer-assisted sperm analysis) systems, laser systems, and consumables for the IVF and andrology markets, overlapping directly with Bonraybio's X1/X3/X12 PRO analyzers and CA0/CA1 separation devices in target customer workflows.

TypeBroad incumbent
Description

Global IVF/ART solutions provider offering media, consumables, and time-lapse incubation systems. Overlaps with Bonraybio's reproductive medicine customer base (IVF clinics, andrology labs) though Vitrolife's portfolio spans female-factor ART rather than male-factor diagnostics.

TypeDirect peer
Description

Spanish developer of the Sperm Class Analyzer (SCA) CASA system for automated sperm analysis. Direct technology competitor to Bonraybio's X1 PRO and X3 PRO semen analyzers, serving andrology labs and IVF centers globally.

TypeBroad incumbent
Description

Supplies cell culture media, reagents, and ART consumables to IVF clinics. Comparable as a global ART consumables leader sharing Bonraybio's clinical fertility customer base, though focused on female-factor and culture media versus Bonraybio's male-factor diagnostics.

TypeBroad incumbent
Description

Large clinical laboratory network with andrology testing services. Represents an adjacent incumbent that could either become a customer for automated semen analysis platforms or a competitive clinical lab alternative for referring physicians.

TypeDirect peer
Description

Develops and commercializes instruments and consumables for IVF laboratories, including sperm preparation and embryo culture systems. Comparable to Bonraybio as a focused ART device vendor targeting clinical fertility workflows with both hardware and consumables.

TypeBroad incumbent
Description

Through Leica Microsystems and Beckman Coulter, Danaher supplies microscopy and flow cytometry platforms used in andrology research and diagnostics. Could integrate competing sperm analysis capabilities or supply flow cytometer-based DNA fragmentation testing as an alternative to Bonraybio's reagent kits.

TypeDirect peer
Description

Manufactures IVF and ART equipment including time-lapse incubators and ART workstations. Comparable as an Asia-based (Singapore) medical device specialist serving the same global IVF clinic and embryology lab customer base as Bonraybio.

TypeBroad incumbent
Description

Major fertility and women's health franchise offering ART media, devices, and genomics services including PGT. Shares Bonraybio's IVF clinic and andrology lab customer segments at scale across global markets.

TypeEmerging player
Description

Smaller software- and instrument-focused entrants in the automated semen analysis and sperm quality assessment market. Comparable to Bonraybio as niche specialists attempting to digitize and standardize andrology workflows with emerging clinical adoption.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries3 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Bonraybio

Medical Diagnostic Devices — Andrology / Male Infertilitybonraybio.com

Bonraybio Co., Ltd. (Taiwan) develops AI-powered male infertility diagnostic solutions under the LensHooke brand — automated semen analyzers, sperm DNA fragmentation test kits, and sperm separation devices — serving IVF clinics, fertility centers, and andrology laboratories across 18+ countries.

What Bonraybio does

Bonraybio Co., Ltd. (邦睿生技股份有限公司) is a Taiwan-based medical device company specializing in male infertility diagnostic solutions under the LensHooke brand. Founded in 2016 by a team with more than 10 years of medical instrument development experience, the company is headquartered in Taichung City, Taiwan, with wholly-owned subsidiary offices in Ontario, California (USA) and Ziyang City, Sichuan (China), and completed its IPO on the Taiwan Stock Exchange (ticker 6955) in December 2024 following a 2023 Emerging Stock Board (興櫃) listing. The company targets IVF centers, fertility clinics, andrology laboratories, and urology practices across more than 18 countries, with a particular focus on the historically underserved male-factor infertility diagnostic workflow.

The company's product portfolio forms an integrated platform called MITS (Male Infertility Total Solution), combining three automated semen analyzers (X1 PRO, X3 PRO, X12 PRO), two sperm DNA fragmentation test kits (R10 Plus, R11 Plus), two sperm separation devices (CA0, CA1), and the C-KUP liquefaction test cup. Core technology is AI-powered computer vision applied to microscopic sperm image analysis, paired with novel sperm chromatin dispersion detection methods; the X12 PRO received FDA 510(k) clearance in June 2025 as the world's first FDA-approved sperm DNA fragmentation test, and CA0/CA1 received FDA approval in October 2022. The IP portfolio comprises 111 global patent applications (93 granted, 18 pending) and 70 registered trademarks across Taiwan, China, the USA, and Europe.

Bonraybio monetizes through a hybrid model combining capital equipment sales (instruments placed at IVF labs and clinics) with recurring consumable reagent sales (R10/R11 Plus test kits tied to installed analyzers), supplemented by aftermarket service. Pricing is quote-based and not publicly disclosed; all sales are executed via an extensive distributor network, with Hamilton Thorne (USA) and nal von minden GmbH (Germany) as core channel partners alongside regional distributors across Italy, South Korea, Thailand, Vietnam, Israel, the UAE, Turkey, and others. The company is heavily event-driven, participating in major reproductive medicine exhibitions (MEDICA, ASRM, ESHRE, CSRM) and conducting global MITS hands-on workshops to train distributors and engage embryologists and andrologists.

Bonraybio firmographics

Firmographics
Name
Bonraybio
Legal name
邦睿生技股份有限公司
Website
https://bonraybio.com
Company type
Public
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Bonraybio Co., Ltd. (Taiwan) develops AI-powered male infertility diagnostic solutions under the LensHooke brand — automated semen analyzers, sperm DNA fragmentation test kits, and sperm separation devices — serving IVF clinics, fertility centers, and andrology laboratories across 18+ countries.
Ownership category
akta.pro rank

Bonraybio industry classification

Industry
Product category
Medical Diagnostic Devices — Andrology / Male Infertility
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAKAOAD
Male Reproductive & Sexual Medicine (Andrology)

Keywords

  • Automated semen analysis
  • Sperm DNA fragmentation testing
  • Male infertility diagnostics
  • IVF laboratory equipment
  • Andrology diagnostic devices

Where Bonraybio is headquartered

Location

Headquarters

HQ city
Taichung
HQ country
Taiwan
HQ region
Asia

Offices3 records

Markets served

Bonraybio business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

  1. Medical Device Hardware Sales: Sale of automated semen analysis instruments (X1 PRO, X3 PRO, X12 PRO) and sperm separation devices (CA0, CA1). These are capital equipment purchases made by IVF laboratories, fertility clinics, and hospitals.
  2. Consumable Reagent Kits: Recurring sales of sperm DNA fragmentation test kits (R10 Plus, R11 Plus) and other reagents. These consumables are used with the company's instruments and represent a recurring revenue stream tied to testing volume.
  3. Aftermarket Services and Support: Technical support, maintenance services, and potentially software updates for installed base of instruments in laboratories worldwide.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractNo public pricing tiers disclosed

Go-to-market motion2 records

Distribution channels9 records

Marketing channels6 records

Bonraybio product offering

Product offering

Core offering

Bonraybio manufactures and sells AI-powered medical diagnostic devices and consumables under the LensHooke brand to provide a complete Male Infertility Total Solution. Its core offerings include automated semen quality analyzers (LensHooke X1 PRO, X3 PRO, X12 PRO), sperm DNA fragmentation test kits (R10 Plus, R11 Plus), sperm separation devices (CA0, CA1) used in IVF preparation, and the C-KUP liquefaction test cup. The portfolio is sold to IVF centers, fertility clinics, andrology laboratories, and urology practices globally through distributors and direct channels.

Product overview

Bonraybio (邦睿生技) offers the LensHooke brand of male infertility diagnostic solutions, consisting of a platform-plus-modules architecture called MITS (Male Infertility Total Solution). The portfolio includes three automated semen analysis systems (X1 PRO, X3 PRO, X12 PRO), two sperm DNA fragmentation test kits (R10 Plus, R11 Plus), and two sperm separation devices (CA0, CA1), plus the C-KUP liquefaction test cup. These products work together to provide comprehensive male fertility testing from basic semen analysis to advanced DNA fragmentation assessment and sperm selection for assisted reproduction.

Differentiator

Problem solved

Functional benefit

Brands

  • LensHooke: Brand for male infertility total solutions including semen analysis systems, sperm DNA fragmentation tests, and sperm separation devices
  • LensHooke MITS

Products and services

  • LensHooke X1 PRO Semen Quality Analyzer Fully-automatic AI-assisted semen quality analyzer for IVF clinics and andrology labs; provides rapid, simple, and standardized examination of pH, sperm concentration, motility, and morphology. Installed in 100+ US labs and clinics since 2019 via Hamilton Thorne.
  • LensHooke X3 PRO Semen Quality Analyzer Automated semen quality analyzer with an easy-to-use design and high-precision features for sperm analysis; targeted at clinical andrology labs and fertility clinics needing reliable routine semen inspection.
  • LensHooke X12 PRO Fully-Automatic Sperm Analysis System Fully-automatic sperm analysis system combining AI-powered semen quality analysis with sperm DNA fragmentation testing on a single platform; intended for IVF clinics, andrology labs, and research institutions performing advanced male fertility diagnostics.
  • LensHooke R10 Plus Sperm DNA Fragmentation Rapid Test Kit Consumable reagent kit using sperm chromatin dispersion technology for rapid, accurate assessment of sperm DNA fragmentation; used by fertility clinics and andrology labs that do not have access to flow cytometry.
  • LensHooke R11 Plus Sperm DNA Fragmentation Test Kit Reagent kit designed to detect sperm DNA double-strand breaks (DSB) — a marker scientifically correlated with miscarriage and embryo aneuploidy; positioned as the only commercially available reagent kit for DSB detection.
  • LensHooke CA0 Sperm Separation Device Sperm separation device using live motile sorting technology for IVF preparation; delivers consistent sperm selection efficiency for both normal and abnormal semen samples without centrifugation. Clinically adopted in leading hospitals including centers in Chengdu, China.
  • LensHooke CA1 Sperm Separation Device Variant of the CA0 sperm separation device providing centrifugation-free sperm selection for fertility treatments; part of the LensHooke live motile sorting product line.
  • C-KUP Liquefaction Test Cup Single-use liquefaction test cup designed to avoid cross-infection risks during semen testing, including coronavirus-related contamination concerns in semen samples; used as a consumable with the LensHooke analyzer workflow.

Quantifiable outcome

  • DFI minimized in samples processed by CA0
  • +3 more outcomes

Companies that use Bonraybio

Customer profile

Named customers5 records

Segments3 records

Ideal customer profiles3 records

Bonraybio technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Bonraybio partnerships and signals

Strategic signal

Partnerships

Eleven partnerships are on record, tiered core, major and minor.

  • Hamilton Thorne Inc.coreChannel Partner/ Reseller/ Distributor · 1 January 2019Exclusive US distributor for LensHooke products including X1 PRO semen analysis system, X12 PRO, and CA0 sperm separation device. Partnership established from 2019. Hamilton Thorne assists Bonraybio with US market exhibitions including ASRM annual meetings. Over 100 US labs and clinics have adopted LensHooke products through this channel.
  • nal von minden GmbHcoreChannel Partner/ Reseller/ DistributorGermany distributor for LensHooke Male Infertility Total Solution portfolio including X1 PRO, R10, X12 PRO, and CA0. Organized MITS workshop in Göttingen, Germany and AGRBM congress participation. Over 80 IVF centers and 300 embryologists engaged through German market activities.
  • Al-RAD LtdmajorChannel Partner/ Reseller/ DistributorIsrael distributor conducting LensHooke marketing events including visits to IVF centers and hospitals for product demonstrations. Received positive feedback on X1 PRO and CA0 products.
  • Al Fahim Healthcare Solutions LLCmajorChannel Partner/ Reseller/ DistributorUAE distributor participating in Medlab Middle East exhibition with Bonraybio. Booth Z6.H20 showcasing LensHooke product line.
  • Fertilife s.r.l.majorChannel Partner/ Reseller/ DistributorItaly distributor for LensHooke products. Organized successful MITS workshop in Milan with 12 reproductive doctors and embryologists. Supported ESHRE 2024 participation.
  • CNC BiotechmajorChannel Partner/ Reseller/ DistributorSouth Korea distributor co-organizing Korean Society reproductive medicine conference and MITS workshops at CNC headquarters. Strong agreement on future trends including sperm DNA fragmentation testing and centrifugation-free sperm separation.
  • Investment Technology Solutions Company LimitedmajorChannel Partner/ Reseller/ DistributorVietnam distributor, one of the leading IVF companies in Vietnam. Organized MITS seminar at Vinmec Hospital Hanoi with 30 doctors and embryologists. Showcased X1 PRO, R10/X12 PRO, and CA0 products.
  • A.P.TEC (Thailand) Co., Ltd.majorChannel Partner/ Reseller/ DistributorThailand distributor co-organizing workshop with ThaiSRM (Thai Society for Reproductive Medicine) and Siam Fertility Clinic. Focused on IUI treatment applications.
  • ARKİM MEDİKALminorChannel Partner/ Reseller/ DistributorTurkey distributor participating in expoMED Eurasia exhibition. Over 100 doctors and visitors engaged at booth.
  • First Capital Securities Corporation (第一金證券)minorOthersStock affairs agent for listed company shareholder services. Contact: 02-2563-5711
  • Toliopoulos DiagnosticsminorChannel Partner/ Reseller/ DistributorSupport partner for ESHRE 2024 exhibition in Amsterdam, Netherlands.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Bonraybio competitors and assessment

Company assessment

Direct peers

  • Hamilton Thorne: Direct competitor and simultaneously Bonraybio's exclusive US distributor for LensHooke products. Hamilton Thorne offers CASA (computer-assisted sperm analysis) systems, laser systems, and consumables for the IVF and andrology markets, overlapping directly with Bonraybio's X1/X3/X12 PRO analyzers and CA0/CA1 separation devices in target customer workflows.
  • Microptic: Spanish developer of the Sperm Class Analyzer (SCA) CASA system for automated sperm analysis. Direct technology competitor to Bonraybio's X1 PRO and X3 PRO semen analyzers, serving andrology labs and IVF centers globally.
  • Genea Biomedx: Develops and commercializes instruments and consumables for IVF laboratories, including sperm preparation and embryo culture systems. Comparable to Bonraybio as a focused ART device vendor targeting clinical fertility workflows with both hardware and consumables.
  • Esco Medical: Manufactures IVF and ART equipment including time-lapse incubators and ART workstations. Comparable as an Asia-based (Singapore) medical device specialist serving the same global IVF clinic and embryology lab customer base as Bonraybio.

Broad incumbents

  • Vitrolife: Global IVF/ART solutions provider offering media, consumables, and time-lapse incubation systems. Overlaps with Bonraybio's reproductive medicine customer base (IVF clinics, andrology labs) though Vitrolife's portfolio spans female-factor ART rather than male-factor diagnostics.
  • FUJIFILM Irvine Scientific: Supplies cell culture media, reagents, and ART consumables to IVF clinics. Comparable as a global ART consumables leader sharing Bonraybio's clinical fertility customer base, though focused on female-factor and culture media versus Bonraybio's male-factor diagnostics.
  • LabCorp: Large clinical laboratory network with andrology testing services. Represents an adjacent incumbent that could either become a customer for automated semen analysis platforms or a competitive clinical lab alternative for referring physicians.
  • Danaher (Leica Microsystems / Beckman Coulter): Through Leica Microsystems and Beckman Coulter, Danaher supplies microscopy and flow cytometry platforms used in andrology research and diagnostics. Could integrate competing sperm analysis capabilities or supply flow cytometer-based DNA fragmentation testing as an alternative to Bonraybio's reagent kits.
  • CooperSurgical (CooperCompanies): Major fertility and women's health franchise offering ART media, devices, and genomics services including PGT. Shares Bonraybio's IVF clinic and andrology lab customer segments at scale across global markets.

Emerging players

  • SciNote / Sperm Tracker (Andrology Solutions): Smaller software- and instrument-focused entrants in the automated semen analysis and sperm quality assessment market. Comparable to Bonraybio as niche specialists attempting to digitize and standardize andrology workflows with emerging clinical adoption.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Bonraybio social profiles

Digital presence

Bonraybio compliance and trust

Trust signal

Compliance1 record

Bonraybio financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Bonraybio leadership team

Management profile

Number of profiles

Profiles3 records

Bonraybio subsidiaries and ownership

Company hierarchy

Subsidiaries3 records

Bonraybio funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Bonraybio M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bonraybio

What does Bonraybio do?

Bonraybio manufactures and sells AI-powered medical diagnostic devices and consumables under the LensHooke brand to provide a complete Male Infertility Total Solution. Its core offerings include automated semen quality analyzers (LensHooke X1 PRO, X3 PRO, X12 PRO), sperm DNA fragmentation test kits (R10 Plus, R11 Plus), sperm separation devices (CA0, CA1) used in IVF preparation, and the C-KUP liquefaction test cup. The portfolio is sold to IVF centers, fertility clinics, andrology laboratories, and urology practices globally through distributors and direct channels.

Is Bonraybio a public or private company?

Bonraybio is a public company. It is classified as public and is currently operating.

When was Bonraybio founded?

Bonraybio was founded in 2016. It employs 11 to 50 people.

Where is Bonraybio based?

Bonraybio is headquartered in Taichung, Taiwan, in the Asia region.

How does Bonraybio make money?

Three revenue lines are on record. Medical Device Hardware Sales are the primary driver. The others are consumable Reagent Kits and aftermarket Services and Support.

Who are Bonraybio's main competitors?

Direct peers on record are Hamilton Thorne, Microptic, Genea Biomedx and Esco Medical. Broad incumbents are Vitrolife, FUJIFILM Irvine Scientific, LabCorp, Danaher (Leica Microsystems / Beckman Coulter) and CooperSurgical (CooperCompanies). SciNote / Sperm Tracker (Andrology Solutions) is listed as an emerging player.

Does Bonraybio have an API?

No public API is recorded for Bonraybio.

What industry is Bonraybio in?

Bonraybio's product category is Medical Diagnostic Devices — Andrology / Male Infertility. Its primary akta.pro industry code is HLAKAOAD, Male Reproductive & Sexual Medicine (Andrology). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales